Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TOUR
2226
Tuniu
TOUR
$53.2M
| $1.85M | ﹤0.01% |
150,710
+29,087
| +24% | +$272K |
|
|
ESXB
2227
DELISTED
Community Bankers Trust Corporation
ESXB
| $1.85M | ﹤0.01% |
337,107
+70,300
| +26% | +$367K |
|
2228
Perrigo
PRGO
$1.81B
| $1.85M | ﹤0.01% |
+33,500
| New | +$1.76M |
|
|
ELVT
2229
DELISTED
Elevate Credit, Inc.
ELVT
| $1.85M | ﹤0.01% |
1,249,955
-241,843
| -16% | -$423K |
|
|
ACGN
2230
DELISTED
Aceragen Inc
ACGN
| $1.85M | ﹤0.01% |
60,763
+24,718
| +69% | +$763K |
|
2231
Ultralife
ULBI
$125M
| $1.84M | ﹤0.01% |
263,064
+28,300
| +12% | +$207K |
|
|
LDL
2232
DELISTED
Lydall, Inc.
LDL
| $1.84M | ﹤0.01% |
135,900
-78,500
| -37% | -$869K |
|
2233
ORIX
IX
$43.6B
| $1.84M | ﹤0.01% |
149,000
-159,000
| -52% | -$1.95M |
|
2234
BlackLine
BL
$1.77B
| $1.83M | ﹤0.01% |
22,100
-69,400
| -76% | -$4.63M |
|
|
RDGT
2235
Ridgetech Inc
RDGT
$3.01M
| $1.83M | ﹤0.01% |
37
+9
| +32% | +$684K |
|
|
HARP
2236
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $1.83M | ﹤0.01% |
11,000
-360
| -3% | -$56.2K |
|
2237
Sonoco
SON
$5.76B
| $1.82M | ﹤0.01% |
+34,900
| New | +$1.73M |
|
2238
First Community Corp
FCCO
$323M
| $1.82M | ﹤0.01% |
120,179
+38,039
| +46% | +$569K |
|
|
MFGP
2239
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
| $1.81M | ﹤0.01% |
330,965
+3,100
| +0.9% | +$17K |
|
2240
Norwegian Cruise Line
NCLH
$8.73B
| $1.81M | ﹤0.01% |
110,334
-1,247,061
| -92% | -$18.3M |
|
2241
Federal Signal
FSS
$7.68B
| $1.8M | ﹤0.01% |
60,700
-123,600
| -67% | -$3.5M |
|
|
RFP
2242
DELISTED
Resolute Forest Products Inc.
RFP
| $1.8M | ﹤0.01% |
851,400
-228,500
| -21% | -$433K |
|
2243
Eagle Bancorp Montana
EBMT
$187M
| $1.79M | ﹤0.01% |
103,174
+22,405
| +28% | +$382K |
|
2244
Sportsman's Warehouse
SPWH
$46.4M
| $1.79M | ﹤0.01% |
+125,528
| New | +$1.18M |
|
|
ARI
2245
Apollo Commercial Real Estate
ARI
$876M
| $1.79M | ﹤0.01% |
182,240
-410,100
| -69% | -$3.48M |
|
2246
AstroNova
ALOT
$227M
| $1.77M | ﹤0.01% |
222,206
+29,396
| +15% | +$193K |
|
|
DALN
2247
DELISTED
DallasNews
DALN
| $1.75M | ﹤0.01% |
253,456
+12,218
| +5% | +$77.6K |
|
2248
Madison Square Garden
MSGS
$9.8B
| $1.75M | ﹤0.01% |
11,900
+8,816
| +286% | +$1.46M |
|
2249
Regal Rexnord
RRX
$11.7B
| $1.75M | ﹤0.01% |
20,000
+10,200
| +104% | +$764K |
|
|
AAT
2250
American Assets Trust
AAT
$1.4B
| $1.74M | ﹤0.01% |
62,500
-21,100
| -25% | -$577K |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.